| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nabriva Therapeutics plc | Gen Counsel & Corp Secretary | Ordinary Shares | 41,194 | $61,791 | $1.50 | 31 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NBRV | Nabriva Therapeutics plc | 31 Aug 2021 | 1 | -$39.22 | 4 | Gen Counsel & Corp Secretary | 02 Sep 2021, 16:06 |
| NBRV | Nabriva Therapeutics plc | 06 Aug 2021 | 1 | -$86.58 | 4 | Gen Counsel & Corp Secretary | 10 Aug 2021, 17:13 |
| NBRV | Nabriva Therapeutics plc | 31 Jul 2021 | 1 | -$40.7 | 4 | Gen Counsel & Corp Secretary | 03 Aug 2021, 16:06 |
| NBRV | Nabriva Therapeutics plc | 06 Jul 2021 | 1 | -$93.98 | 4 | Gen Counsel & Corp Secretary | 08 Jul 2021, 16:09 |
| NBRV | Nabriva Therapeutics plc | 30 Jun 2021 | 1 | -$49.95 | 4 | Gen Counsel & Corp Secretary | 02 Jul 2021, 16:04 |
| NBRV | Nabriva Therapeutics plc | 06 Jun 2021 | 1 | -$97.82 | 4 | Gen Counsel & Corp Secretary | 08 Jun 2021, 16:05 |
| NBRV | Nabriva Therapeutics plc | 31 May 2021 | 1 | -$51.06 | 4 | Gen Counsel & Corp Secretary | 02 Jun 2021, 16:11 |
| NBRV | Nabriva Therapeutics plc | 06 May 2021 | 1 | -$110 | 4 | Gen Counsel & Corp Secretary | 10 May 2021, 17:51 |